Chemotherapy News and Research

Latest Chemotherapy News and Research

A single round of chemotherapy has no effect on sperm count, say researchers

Men with early-stage testicular can safely undergo one round of post-operative chemotherapy or radiotherapy without a long-term negative effect on sperm count.

25 Feb 2019

Sperm quality not affected by one course of postoperative treatment for early testicular cancer

Men with early stage testicular cancer can safely receive one course of chemotherapy or radiotherapy after surgery without it having a long-term effect on their sperm count, according to a study published in the leading cancer journal Annals of Oncology today (Monday).

25 Feb 2019

Researchers find increased rates of CRC screening in Kentucky after Medicaid expansion

Kentucky is one of the poorest states in the U.S. However, the state has been one of the most successful in reducing its uninsured rate, which happened in part through the Affordable Care Act's Medicaid expansion that took effect on January 1, 2014.

23 Feb 2019

New identified biomarker predicts patients who might benefit from HER2-targeted agents

In an effort to further individualize therapy and avoid over-treating patients, researchers at the Johns Hopkins Kimmel Cancer Center report a new study using PET scans has identified a biomarker that may accurately predict which patients with one type of HER2-positive breast cancer might best benefit from standalone HER2-targeted agents, without the need for standard chemotherapy.

22 Feb 2019

Study: Cancer stem-like cells are maintained by MTHFD2 mitochondrial metabolic enzyme

An increase in the incidence and mortality rate of cancer has been noted worldwide, especially for lung cancer.

22 Feb 2019

New AI can identify, predict development of different combinations of cancer symptoms

Cancer patients who undergo chemotherapy could soon benefit from a new AI that is able to identify and predict the development of different combinations of symptoms - helping to alleviate much of the distress caused by their occurrence and severity.

20 Feb 2019

Study suggests new treatment strategy for deadly brain cancer

In a study of mice and human brain tumors researchers at the University of the Michigan, Ann Arbor, searched for new treatments by exploring the reasons why some patients with gliomas live remarkably longer than others.

19 Feb 2019

Early marker of cardiac damage triggered by cancer treatment identified

Every year, 4 million new cases of cancer are diagnosed in Europe. Advances in cancer treatment sometimes come at the cost of major adverse effects, and one of the most prominent is cardiotoxicity. Myocardial toxicity affects as many as 25% of patients undergoing treatment with commonly used anticancer drugs.

19 Feb 2019

Researchers report progress in the treatment of aggressive brain tumors

Cancer researchers at the University of Bonn have reported significant progress in the treatment of glioblastoma. About one third of all patients suffer from a particular variant of this most common and aggressive brain tumor.

18 Feb 2019

New software found to be four times better at predicting the prognosis of ovarian cancer

A new tool has proved to be four times more reliable at predicting prognosis in patients with ovarian cancer and the most effective course of treatment.

18 Feb 2019

Combination of PARP inhibitor and immunotherapy results in tumor regression in SCLC mouse models

Researchers at The University of Texas MD Anderson Cancer Center have discovered that a combination of immune checkpoint blockade and targeted therapies that block normal DNA damage repair achieved significant tumor regression in mouse models of small cell lung cancer, suggesting a promising new approach for treating patients with this aggressive cancer.

18 Feb 2019

Columbia researchers unravel why some glioblastomas respond to immunotherapy

Columbia researchers have learned why some glioblastomas--the most common type of brain cancer--respond to immunotherapy. The findings could help identify patients who are most likely to benefit from treatment with immunotherapy drugs and lead to the development of more broadly effective treatments.

17 Feb 2019

Artificial intelligence can accurately predict prognosis of ovarian cancer patients

The artificial intelligence software, created by researchers at Imperial College London and the University of Melbourne, has been able to predict the prognosis of patients with ovarian cancer more accurately than current methods. It can also predict what treatment would be most effective for patients following diagnosis.

15 Feb 2019

Castration-resistant metastatic prostate cancer responds to combination of immune checkpoint inhibitors

Some patients with metastatic prostate cancer respond to a combination of immune checkpoint inhibitors after hormonal therapy and chemotherapy have failed, according to early results from a clinical trial led by investigators at The University of Texas MD Anderson Cancer Center presented today at the American Society of Clinical Oncology Genitourinary Cancers Symposium in San Francisco.

15 Feb 2019

Discovery of weakness in a rare cancer could be exploited with drugs

Cancer cells are, in some respects, impressive: They can grow relentlessly, sidestep the aging process by becoming immortal, and evade the immune system's persistent attacks. But in the process of acquiring such superpowers, the cells must occasionally relinquish other, more mundane skills--including the ability to produce certain nutrients.

15 Feb 2019

WVU gynecologic oncologist investigates novel treatment for cervical and vaginal cancers

Cervical cancer can be insidious. Changes to the cervix are often detected with a pap smear, but for those with limited access to health care, cervical and vaginal cancers can go unnoticed for years--silently growing, spreading and invading other organs--and by the time they're detected, they may be so advanced that the patient's prognosis is poor and her treatment options few.

15 Feb 2019

New reversible antiplatelet therapy could reduce risk of blood clots, prevent cancer metastasis

A new reversible, drug-free antiplatelet therapy could reduce the risk of blood clots and potentially prevent cancer metastasis, according to a study published today in Science Translational Medicine.

14 Feb 2019

Photoacoustic imaging accurately measures the temperature of deep tissues

Measuring a fever is usually pretty simple: place a thermometer under a patient's tongue and get an accurate temperature reading within 30 seconds. But that simplicity does not translate when it comes to measuring the temperatures of specific tissues deep inside the body.

14 Feb 2019

Novel approach uses small amounts of tissue to quantify PD-L1 expression levels in tumors

Immune checkpoint inhibitors, such as the anti-PD-1 antibody pembrolizumab, have become important tools for managing non-small-cell lung cancer.

14 Feb 2019

Few primary care physicians lack enough knowledge of cancer treatment options

The idea of team-based cancer care most often focuses on involving primary care physicians in the care of cancer survivors. But research has shown patients are discussing initial cancer treatment options with their primary care doctors.

13 Feb 2019

Chemotherapy News and Research

Latest Chemotherapy News and Research

A single round of chemotherapy has no effect on sperm count, say researchers

Sperm quality not affected by one course of postoperative treatment for early testicular cancer

Researchers find increased rates of CRC screening in Kentucky after Medicaid expansion

New identified biomarker predicts patients who might benefit from HER2-targeted agents

Study: Cancer stem-like cells are maintained by MTHFD2 mitochondrial metabolic enzyme

New AI can identify, predict development of different combinations of cancer symptoms

Study suggests new treatment strategy for deadly brain cancer

Early marker of cardiac damage triggered by cancer treatment identified

Researchers report progress in the treatment of aggressive brain tumors

New software found to be four times better at predicting the prognosis of ovarian cancer

Combination of PARP inhibitor and immunotherapy results in tumor regression in SCLC mouse models

Columbia researchers unravel why some glioblastomas respond to immunotherapy

Artificial intelligence can accurately predict prognosis of ovarian cancer patients

Castration-resistant metastatic prostate cancer responds to combination of immune checkpoint inhibitors

Discovery of weakness in a rare cancer could be exploited with drugs

WVU gynecologic oncologist investigates novel treatment for cervical and vaginal cancers

New reversible antiplatelet therapy could reduce risk of blood clots, prevent cancer metastasis

Photoacoustic imaging accurately measures the temperature of deep tissues

Novel approach uses small amounts of tissue to quantify PD-L1 expression levels in tumors

Few primary care physicians lack enough knowledge of cancer treatment options

Cancer Research - Second Edition eBook

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Chemotherapy News and Research

Latest Chemotherapy News and Research

Cancer Research - Second Edition eBook

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Newsletters you may be interested in